Kanad Das

Bioluminescence Ventures is a leading biotechnology venture capital firm that invests in the future of medicine.

Bristol-Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.

Raised $23,580,000,000.00 from RA Capital Management, OUP (Osage University Partners), Aperture Venture Partners, Greg Bailey, Connecticut Innovations, Knoll Capital Management, Vivo Capital, Venrock, Litmore Capital and Carl Icahn.

Libra Therapeutics is a biotechnology company.

Raised $29,000,000.00 from Yonjin Venture, Sante Ventures, Dolby Family Ventures, Sixty Degree Capital, Epidarex Capital and Boehringer Ingelheim Venture Fund.

Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.

Raised $59,500,000.00 from Boehringer Ingelheim Venture Fund, Panacea Venture, JLo Ventures, Illumina Ventures, GKCC, Korea Investment Partners, Illumina Ventures, JLo Ventures, Boehringer Ingelheim Venture Fund and Panacea Venture.

OncoMyx Therapeutics develops oncolytic immunotherapies to assist in creating an immune response and treat cancer.

Raised $50,000,000.00 from Delos Capital, Madison Partners, Xeraya Capital, City Hill Ventures, Boehringer Ingelheim Venture Fund, Lumira Ventures, B Capital, Korea Investment Partners and LYZZ Capital.

Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.

Raised $5,586,000.00 from Private Capital Advisors.